Cargando…
Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?
Increased cardiovascular morbidity and mortality has been associated with the hyperphosphatemia seen in patients with end-stage chronic kidney disease (CKD). Oral phosphate binders are prescribed in these patients to prevent intestinal absorption of dietary phosphate and reduce serum phosphate. In p...
Autores principales: | Negri, Armando Luis, Ureña Torres, Pablo Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370297/ https://www.ncbi.nlm.nih.gov/pubmed/25815172 http://dx.doi.org/10.1093/ckj/sfu139 |
Ejemplares similares
-
Do we need new phosphate binders in dialysis?
por: Cozzolino, Mario, et al.
Publicado: (2020) -
Pharmacology of the Phosphate Binder, Lanthanum Carbonate
por: Damment, Stephen JP
Publicado: (2011) -
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide
por: Cernaro, Valeria, et al.
Publicado: (2016) -
Effectiveness and cost-efficiency of phosphate binders in hemodialysis
por: Fröschl, Barbara, et al.
Publicado: (2009) -
Preparation of acid aluminum phosphate solutions for metakaolin phosphate geopolymer binder
por: Yankwa Djobo, Jean Noël, et al.
Publicado: (2021)